DS

Diptanu Saha

Active Director Designated Partner DIN 09080701
DIN 09080701 First appointment Feb 2021 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Diptanu Saha

Data last updated:

Diptanu Saha is a Designated Partner at Emoleculare Vets Pharma Llp (since 2021). The company operates in Home Appliances.

DIN 09080701
Primary Designation Designated Partner
Industry Home Appliances
First Appointment 24 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Feb 20212021Active

Board colleagues of Diptanu Saha

NameDINCompanyDesignation
Ashis Kanti Pal09080700Emoleculare Vets Pharma LlpDesignated Partner
Subankar Debnath09064058Emoleculare Vets Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Emoleculare Vets Pharma Llp
Premium access

Shareholding and investment profile for Diptanu Saha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Diptanu Saha

Diptanu Saha currently holds 1 directorship: Emoleculare Vets Pharma Llp (Designated Partner, since 24 Feb 2021).

Diptanu Saha was first appointed on 24 Feb 2021 as Designated Partner at Emoleculare Vets Pharma Llp.

The current boards of Diptanu Saha's companies include Ashis Kanti Pal (Emoleculare Vets Pharma Llp), Subankar Debnath (Emoleculare Vets Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available